Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW 75,700
+9,300 (14.01%)
At close: Mar 6, 2026
Next Biomedical Revenue
Next Biomedical had revenue of 4.93B KRW in the quarter ending September 30, 2025, with 125.07% growth. This brings the company's revenue in the last twelve months to 14.90B, up 70.64% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.
Revenue (ttm)
14.90B
Revenue Growth
+70.64%
P/S Ratio
38.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
574.27B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ASTERASYS Co.,Ltd | 36.47B |
| MEDIANA Co.,Ltd | 59.83B |
| L&K Biomed | 40.33B |
| SELVAS Healthcare | 29.79B |
| Remed | 24.26B |
| Noul Co.,Ltd. | 3.91B |
| QuantaMatrix | 3.35B |
| Hironic | 33.18B |